<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A 19-year-old woman with newly diagnosed <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) presented with <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, tonic-clonic <z:hpo ids='HP_0001250'>seizures</z:hpo>, blurry vision, <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> and <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>INVESTIGATIONS: At a general hospital, the investigations included brain MRI, echocardiography, laboratory tests including measurement of the amount of protein excreted daily, platelet count, levels of <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase, <z:chebi fb="0" ids="16737">creatinine</z:chebi> and anticardiolipin antibodies, direct Coombs' test, peripheral blood smear, and measurement of blood pressure </plain></SENT>
<SENT sid="2" pm="."><plain>At a tertiary institution the investigations included physical examination, electroencephalography, brain MRI, magnetic resonance angiography, repetition of laboratory tests plus measurement of <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor-cleaving protease activity, measurement of levels of antibodies to <z:chebi fb="0" ids="4705">double-stranded DNA</z:chebi> and platelets, and renal biopsy </plain></SENT>
<SENT sid="3" pm="."><plain>DIAGNOSIS: Thrombotic <z:hpo ids='HP_0001937'>microangiopathic hemolytic anemia</z:hpo> with a possible underlying diagnosis of malignant <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, catastrophic <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, thrombotic thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo>, or active SLE </plain></SENT>
<SENT sid="4" pm="."><plain>MANAGEMENT: At the general hospital, therapy included a single dose of intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> 500 mg, eight daily plasma exchange treatments, three daily infusions of <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> 1 g followed by <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> 60 mg every 8 h, an infusion of rituximab 657 mg and ultrafiltration via hemodialysis </plain></SENT>
<SENT sid="5" pm="."><plain>At the tertiary institution, therapy included an infusion of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> 650 mg, aspirin 81 mg daily, <z:chebi fb="0" ids="8382">prednisone</z:chebi> 40 mg daily, <z:chebi fb="0" ids="168396">mycophenolate</z:chebi> mofetil 750 mg twice daily, and aggressive management of <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
</text></document>